A Comprehensive Guide to Toxicology in Nonclinical Drug Development
eBook - ePub
Available until 21 Sep |Learn more

A Comprehensive Guide to Toxicology in Nonclinical Drug Development

  1. 1,020 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub
Available until 21 Sep |Learn more

A Comprehensive Guide to Toxicology in Nonclinical Drug Development

Book details
Table of contents
Citations

About This Book

A Comprehensive Guide to Toxicology in Nonclinical Drug Development, Third Edition is a valuable reference providing a complete understanding of all aspects of nonclinical toxicology in pharmaceutical research. This updated edition has been expanded and re-developed covering a wide-range of toxicological issues in small molecules and biologics. Topics include ADME in drug discovery, pharmacokinetics, toxicokinetics, formulations, and genetic toxicology testing. The book has been thoroughly updated throughout to reflect the latest scientific advances and includes new information on antiviral drugs, anti-diabetic drugs, immunotherapy, and a discussion on post-pandemic drug development challenges and opportunities. This is an essential and practical resource for all toxicologists involved in nonclinical testing in industry, academic, and regulatory settings.

  • Provides updated, unique content not covered in one comprehensive resource, including chapters on stem cells, antiviral drugs, anti-diabetic drugs, and immunotherapy
  • Includes the latest international guidelines for nonclinical toxicology in both small and large molecules
  • Incorporates practical examples in order to illustrate day-to-day activities and expectations associated with working in nonclinical toxicology

Frequently asked questions

Simply head over to the account section in settings and click on “Cancel Subscription” - it’s as simple as that. After you cancel, your membership will stay active for the remainder of the time you’ve paid for. Learn more here.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Both plans give you full access to the library and all of Perlego’s features. The only differences are the price and subscription period: With the annual plan you’ll save around 30% compared to 12 months on the monthly plan.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes, you can access A Comprehensive Guide to Toxicology in Nonclinical Drug Development by Ali S. Faqi in PDF and/or ePUB format, as well as other popular books in Medicine & Pharmacology. We have over one million books available in our catalogue for you to explore.

Information

Publisher
Academic Press
Year
2024
ISBN
9780323984621
Edition
3
Topic
Medicine
Subtopic
Pharmacology

Table of contents

  1. Cover image
  2. Title page
  3. Table of Contents
  4. Copyright
  5. Dedication
  6. Contributors
  7. Preface
  8. Section I. Drug Discovery, Metabolism, and Toxicokinetic
  9. Section II. Toxicological Studies and IND Application and First-In-Human Clinical Trial and Abuse Liability
  10. Section III. Clinical Pathology, Toxicological Pathology, Molecular Biology, and Biomarkers
  11. Section IV. Biostatistics, Regulatory Toxicology, and Role of Study Directors
  12. Section V. Specialty Route of Administration
  13. Section VI. Nonclinical Development of Monoclonal Antibodies, Stem Cells, Oncogenic and Non-Oncogenic Drugs, Oligonucleotides, and Vaccines
  14. Section VII. Nonclinical Development of Oncogenic and Nononcogenic Drugs and Oligonucleotidebased Therapies and Vaccines
  15. Section VIII. Safety Evaluation of Ocular Drugs, Botanical Products, and Medicinal Devices
  16. Section IX. Predictive Toxicology and Imaging
  17. Index